Antineoplastic drug

Focus of product manufacturers on single-use technology to maintain quality of biologic parenteral drugs is a key factor for parenteral drugs market to face upward growth in the forthcoming years, says a market intelligence report on parenteral drugs market by Fact.MR Clinically, parenteral drug administration is the most usual route of administration of a drug, after oral administration, due to the benefits that it offers. Benefits such as more bioavailability of the active pharmaceutical ingredient with limited therapeutic index are likely to widen the scope of the global parenteral drug market in the years to come, from 2019 to 2029.

In addition to that, rapid advancement in the field of biological and biosimilars products together with augmented utilization of the system of controlled drug delivery is likely to foster the growth of the global parenteral drug market in the years to come. High-end drug delivery gadgets can diminish the total number of injections in the drug delivery therapy through the mechanism of sustained release of the drug. This is of high economic and medical significance.

Some of the leading manufacturers in the global parenteral drug market are Bristol-Myers Squibb Company, Abbott Laboratories, Pfizer Incorporated, Becton, Dickinson and Company, Baxter International Incorporated, and GlaxoSmithKline plc

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Parenteral Drugs market during the historical period of 2014 – 2018. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2019, and key prospects over the forecast period 2019 – 2029.

On this premise, the parenteral drugs market is poised to reach a staggering valuation of US $ 802Bn by the end of the forecast period (2019-2029). Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the Antibiotics Drugs market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Parenteral Drugs market.

After reading the Parenteral Drugs market report, readers get insight into: